UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 122

Sortiert nach

Clinical Pharmacokinetics and Pharmacodynamics of Monoclonal Antibodies Approved to Treat Rheumatoid Arthritis

Clinical pharmacokinetics, 2015-11, Vol.54 (11), p.1107-1123

2015

Link zum Volltext

Verfügbarkeit prüfen

Antibiotic treatment for 6 weeks versus 12 weeks in patients with pyogenic vertebral osteomyelitis: an open-label, non-inferiority, randomised, controlled trial

The Lancet (British edition), 2015-03, Vol.385 (9971), p.875-882

2015

Link zum Volltext

Verfügbarkeit prüfen

A Comparative Study of Fibromyalgia, Rheumatoid Arthritis, Spondyloarthritis, and Sjögren’s Syndrome; Impact of the Disease on Quality of Life, Psychological Adjustment, and Use of Coping Strategies

Pain medicine (Malden, Mass.), 2021-02, Vol.22 (2), p.372-381

2021

Link zum Volltext

Verfügbarkeit prüfen

Machine learning reveals the most important psychological and social variables predicting the differential diagnosis of rheumatic and musculoskeletal diseases

Rheumatology international, 2022-06, Vol.42 (6), p.1053-1062

2022

Link zum Volltext

Verfügbarkeit prüfen

Increased high molecular weight adiponectin and lean mass during tocilizumab treatment in patients with rheumatoid arthritis: a 12-month multicentre study

Arthritis research & therapy, 2020-09, Vol.22 (1), p.1-224, Article 224

2020

Link zum Volltext

Verfügbarkeit prüfen

Joint manifestations revealing inborn metabolic diseases in adults: a narrative review

Orphanet journal of rare diseases, 2023-08, Vol.18 (1), p.239-239, Article 239

2023

Link zum Volltext

Verfügbarkeit prüfen

Relationship between inflammation and infliximab pharmacokinetics in rheumatoid arthritis

British journal of clinical pharmacology, 2014-07, Vol.78 (1), p.118-128

2014

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetics and concentration–effect relationship of adalimumab in rheumatoid arthritis

British journal of clinical pharmacology, 2015-02, Vol.79 (2), p.286-297

2015

Link zum Volltext

Verfügbarkeit prüfen

IgG1 Allotypes Influence the Pharmacokinetics of Therapeutic Monoclonal Antibodies through FcRn Binding

The Journal of immunology (1950), 2016-01, Vol.196 (2), p.607-613

2016

Link zum Volltext

Verfügbarkeit prüfen

Non-severe eosinophilic granulomatosis with polyangiitis: long-term outcomes after remission-induction trial

Rheumatology (Oxford, England), 2019-12, Vol.58 (12), p.2107-2116

2019

Link zum Volltext

Verfügbarkeit prüfen

Antigenic burden and serum IgG concentrations influence rituximab pharmacokinetics in rheumatoid arthritis patients

British journal of clinical pharmacology, 2017-08, Vol.83 (8), p.1773-1781

2017

Link zum Volltext

Verfügbarkeit prüfen

Bispecific antibodies tethering innate receptors induce human tolerant-dendritic cells and regulatory T cells

Frontiers in immunology, 2024-03, Vol.15, p.1369117-1369117

2024

Link zum Volltext

Verfügbarkeit prüfen

Predictors of response to TNF inhibitors in rheumatoid arthritis: an individual patient data pooled analysis of randomised controlled trials

Rheumatic & musculoskeletal diseases open, 2021-11, Vol.7 (3), p.e001882

2021

Link zum Volltext

Verfügbarkeit prüfen

Therapeutic drug monitoring of biopharmaceuticals in inflammatory rheumatic and musculoskeletal disease: a systematic literature review informing EULAR points to consider

RMD Open, 2022-06, Vol.8 (2), p.e002216

2022

Link zum Volltext

Verfügbarkeit prüfen

Methotrexate effect on immunogenicity and long-term maintenance of adalimumab in axial spondyloarthritis: a multicentric randomised trial

Rheumatic & musculoskeletal diseases open, 2020-01, Vol.6 (1), p.e001047

2020

Link zum Volltext

Verfügbarkeit prüfen

Points to consider for cost-effective use of biological and targeted synthetic DMARDs in inflammatory rheumatic diseases: results from an umbrella review and international Delphi study

Rheumatic & musculoskeletal diseases open, 2023-03, Vol.9 (1), p.e002898

2023

Link zum Volltext

Verfügbarkeit prüfen

Infliximab Efficacy May Be Linked to Full TNF-α Blockade in Peripheral Compartment—A Double Central-Peripheral Target-Mediated Drug Disposition (TMDD) Model

Pharmaceutics, 2021-11, Vol.13 (11), p.1821

2021

Link zum Volltext

Verfügbarkeit prüfen

Pathophysiology of disk-related sciatica. I.—Evidence supporting a chemical component

Joint, bone, spine : revue du rhumatisme, 2006-03, Vol.73 (2), p.151-158

2006

Link zum Volltext

Verfügbarkeit prüfen

Adalimumab concentration-based tapering strategy: as good as the recommended dosage

Annals of the rheumatic diseases, 2018-04, Vol.77 (4), p.473

2018

Link zum Volltext

Verfügbarkeit prüfen

Exposure–Response Relationship of Certolizumab Pegol and Achievement of Low Disease Activity and Remission in Patients With Rheumatoid Arthritis

Clinical and translational science, 2020-07, Vol.13 (4), p.743-751

2020

Link zum Volltext

Verfügbarkeit prüfen

Infliximab concentration monitoring improves the control of disease activity in rheumatoid arthritis

Arthritis research & therapy, 2009-01, Vol.11 (6), p.R178-R178

2009

Link zum Volltext

Verfügbarkeit prüfen

Do immunoglobulin levels and CD4 cell count interact during Rituximab treatment?

Arthritis & rheumatology (Hoboken, N.J.), 2014-01

Mulleman, Denis

2014

Link zum Volltext

Verfügbarkeit prüfen

Rheumatology, the multitude of options

M.S. Médecine sciences, 2020-01, Vol.35 (12), p.1029

2020

Link zum Volltext

Verfügbarkeit prüfen

Large increase of vertebral osteomyelitis in France: a 2010–2019 cross-sectional study

Epidemiology and infection, 2021-10, Vol.149, p.e227-e227, Article e227

2021

Link zum Volltext

Verfügbarkeit prüfen

Streptococcal and enterococcal spondylodiscitis (vertebral osteomyelitis). High incidence of infective endocarditis in 50 cases

Journal of rheumatology, 2006-01, Vol.33 (1), p.91

2006

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 122

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(98)
Mit Volltextzugriff
(102)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(85)
Science & Technology
(85)
Humans
(70)
Life Sciences
(55)
Rheumatology
(46)
Female
(37)
Male
(34)
Middle Aged
(32)
Aged
(30)
Rheumatoid Arthritis
(30)
Human Health And Pathology
(29)
Adult
(27)
Pharmacology & Pharmacy
(24)
Monoclonal Antibodies
(23)
Arthritis, Rheumatoid - Drug Therapy
(20)
Rhumatology And Musculoskeletal System
(20)
Infliximab
(19)
Treatment Outcome
(18)
Pharmacokinetics
(16)
Antirheumatic Agents - Therapeutic Use
(15)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Clinical Pharmacokinetics and Pharmacodynamics of Monoclonal Antibodies Approved to Treat Rheumatoid Arthritis

Antibiotic treatment for 6 weeks versus 12 weeks in patients with pyogenic vertebral osteomyelitis: an open-label, non-inferiority, randomised, controlled trial

A Comparative Study of Fibromyalgia, Rheumatoid Arthritis, Spondyloarthritis, and Sjögren’s Syndrome; Impact of the Disease on Quality of Life, Psychological Adjustment, and Use of Coping Strategies

Machine learning reveals the most important psychological and social variables predicting the differential diagnosis of rheumatic and musculoskeletal diseases

Increased high molecular weight adiponectin and lean mass during tocilizumab treatment in patients with rheumatoid arthritis: a 12-month multicentre study

Joint manifestations revealing inborn metabolic diseases in adults: a narrative review

Relationship between inflammation and infliximab pharmacokinetics in rheumatoid arthritis

Pharmacokinetics and concentration–effect relationship of adalimumab in rheumatoid arthritis

IgG1 Allotypes Influence the Pharmacokinetics of Therapeutic Monoclonal Antibodies through FcRn Binding

Non-severe eosinophilic granulomatosis with polyangiitis: long-term outcomes after remission-induction trial

Antigenic burden and serum IgG concentrations influence rituximab pharmacokinetics in rheumatoid arthritis patients

Bispecific antibodies tethering innate receptors induce human tolerant-dendritic cells and regulatory T cells

Predictors of response to TNF inhibitors in rheumatoid arthritis: an individual patient data pooled analysis of randomised controlled trials

Therapeutic drug monitoring of biopharmaceuticals in inflammatory rheumatic and musculoskeletal disease: a systematic literature review informing EULAR points to consider

Methotrexate effect on immunogenicity and long-term maintenance of adalimumab in axial spondyloarthritis: a multicentric randomised trial

Points to consider for cost-effective use of biological and targeted synthetic DMARDs in inflammatory rheumatic diseases: results from an umbrella review and international Delphi study

Infliximab Efficacy May Be Linked to Full TNF-α Blockade in Peripheral Compartment—A Double Central-Peripheral Target-Mediated Drug Disposition (TMDD) Model

Pathophysiology of disk-related sciatica. I.—Evidence supporting a chemical component

Adalimumab concentration-based tapering strategy: as good as the recommended dosage

Exposure–Response Relationship of Certolizumab Pegol and Achievement of Low Disease Activity and Remission in Patients With Rheumatoid Arthritis

Infliximab concentration monitoring improves the control of disease activity in rheumatoid arthritis

Do immunoglobulin levels and CD4 cell count interact during Rituximab treatment?

Rheumatology, the multitude of options

Large increase of vertebral osteomyelitis in France: a 2010–2019 cross-sectional study

Streptococcal and enterococcal spondylodiscitis (vertebral osteomyelitis). High incidence of infective endocarditis in 50 cases

Suchergebnisse filtern